EquityZen Growth Technology Fund LLC - Series 2102
Raised
$522K
Investors
37
Min Invest
$5,040
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2102 is a Delaware-domiciled pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett, raising $522K from 37 investors under Rule 506(b) and Section 3(c)(1) exemptions. The fund maintains a $5K minimum investment and is part of EquityZen's pre-IPO investment platform, which operates 1,889 related EDGAR entities. First sale date was not disclosed in this October 2025 filing.
This pre-IPO vehicle follows the standard EquityZen series fund model, using dual 506(b)/3(c)(1) exemptions typical of private company secondary market access funds. The $5K minimum investment reflects a retail-accessible tier within the alternative investment category, consistent with EquityZen's platform approach to democratizing pre-IPO equity exposure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
